Investors Put Together $13M More for Acid Reflux Treatment
June 25, 2012- Share:
EndoGastric Solutions, a developer of treatment for Gastroesophageal Reflux Disease (GERD), has netted an internal round of financing that's an extension of its 2010 Series F funding. Existing investors including Advanced Technology Ventures, Canaan Partners, Chicago Growth Partners, De Novo Ventures, Foundation Medical Partners, Oakwood Medical Investors and Radius Ventures participated in the $13 million round, bringing the company's total Series F funding up to $43 million.
- Share:
-
-
-
-